Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation

Articles in Press

Peer-reviewed, accepted articles are posted in Articles in Press shortly after editorial acceptance. These posted articles (below) have completed a rigorous peer review process but the articles have NOT been copyedited or designed. Copyedited, designed, final versions of these articles will be created and published in a Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (JCOPDF) upcoming issue. Articles in Press citations/abstracts are submitted to PubMed.

To receive notifications of the posting of new Articles in Press AND the posting of new JCOPDF issues, sign up for a FREE SUBSCRIPTION HERE.


Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study

Adel Boueiz1,2*, Zhonghui Xu1*, Yale Chang3, Aria Masoomi3, Andrew Gregory1, Sharon M. Lutz4, Dandi Qiao1, James D. Crapo5, Jennifer G. Dy3, Edwin K. Silverman1,2, Peter J. Castaldi1,6, for the COPDGene Investigators

Citation: Boueiz A, Xu Z, Chang Y, et al. Machine learning prediction of progression in forced expiratory volume in 1 second (FEV1) in the CODPGene® study. Chronic Obstr Pulm Dis. 2022; Published online May 20, 2022. doi: https://doi.org/10.15326/jcopdf.2021.0275


Circulating 1,3-Beta-D-Glucan is Associated with Lung Function, Respiratory Symptoms, and Mediators of Matrix Degradation in Chronic Obstructive Pulmonary Disease

Matthew Gorgone, DO1* Deepti Singhvi, MD1* Seyed Mehdi Nouraie, MD1 Malcolm Finkelman, PhD2 Yonglong Zhang, PhD2 Jiantao Pu, PhD3 Divay Chandra, MD1 Yingze Zhang, PhD1 Georgios D Kitsios, MD, PhD1,4 Alison Morris, MD, MS1,4 Frank C. Sciurba, MD1 Jessica Bon, MD, MS1, 5

Citation: Gorgone M, Singhvi D, Nouraie SM, et al. Circulating 1,3-beta-d-glucan is associated with lung function, respiratory symptoms, and mediators of matrix degradation in chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2022; Published online May 11, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0290


Giving Voice to People – Experiences During Mild to Moderate Acute Exacerbations of COPD

Ana Machado1,2,3,4,5 Sara Almeida1,2 Chris Burtin4,5 Alda Marques1,2

Citation: Machado A, Almeida S, Burtin C, Marques A. Giving voice to people – experiences during mild to moderate acute exacerbations of COPD. Chronic Obstr Pulm Dis. 2022; Published online May 6, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0283


Differences of the Nasal Microbiome and Mycobiome by Clinical Characteristics of COPD Patients

Maura Alvarez-Baumgartner1, Chengchen Li2, Thomas Kuntz2, Lina Nurhussien1, Andrew J. Synn1, Wendy Y. Sun1, Jennifer E. Kang1, Peggy Lai3, Jeremy E. Wilkinson2, Mary B. Rice1

Citation: Alvarez-Baumgartner M, Li C, Kuntz T, et al. Differences of the nasal microbiome and mycobiome by clinical characteristics of COPD patients. Chronic Obstr Pulm Dis. 2022; Published online April 29, 2022. doi: https://doi.org/10.15326/jcopdf.2021.0267


Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life

Erin R Camac DO, FCCP1 Natalie A Stumpf BA2 Helen K Voelker, BS3 and Gerard J Criner, MD, ATSF, FCCP2 for the COPD Clinical Research Network and the Canadian Institutes of Health Research

Citation: Camac ER, Stumpf NA, Voelker HK, Criner GJ. Short-term impact of the frequency of COPD exacerbations on quality of life. Chronic Obstr Pulm Dis. 2022; Published online April 1, 2022. doi: https://doi.org/10.15326/jcopdf.2021.0280